CELSET Launches SOLTOX, a Korean Botulinum Toxin Type A Brand, for International Markets

The Quick Take
SEOUL, South Korea, Oct. 28, 2026 /PRNewswire/ -- CELSET INC., a Korean biotechnology company specializing in medical aesthetics, has launched SOLTOX, its botulinum toxin type A brand, introducing a Korean botulinum toxin brand to the international medical aesthetics industry. SOLTOX is...
Ground Level News gathers headlines from public news feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire.


